MOACM
BMY.RT

Mutual of America Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Mutual of America Capital Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,537
Closed -$5K – 1686
2020
Q4 		$5K Hold
7,537
– – ﹤0.01% 1668
2020
Q3 		$17K Sell
7,537
-220
-3% -$628 ﹤0.01% 1651
2020
Q2 		$28K Sell
7,757
-23,398
-75% -$84.4K ﹤0.01% 1485
2020
Q1 		$118K Sell
31,155
-485
-2% -$1.6K ﹤0.01% 1168
2019
Q4 		$95K Buy
+31,640
New +$82.3K ﹤0.01% 1208

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $245M AUM 15.03% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Mutual of America Capital Management's BMY.RT Position: Q1 2021 in Review

Mutual of America Capital Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 7,537 shares — an estimated $5K sold.

Mutual of America Capital Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $118K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Mutual of America Capital Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Mutual of America Capital Management sold 7,537 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $5K.
  • Mutual of America Capital Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Mutual of America Capital Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $118K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Mutual of America Capital Management's 13F filing for Q1 2021, filed 13 May 2021.